SEC Form D · filed August 3, 2020
GENOCEA BIOSCIENCES, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Lisa L. Silverstein · New York, NYExecGeorge Siber · North Cambridge, MADirectorJordan Jones · Birmingham, ALExecSwaroop Kolluri · Cambridge, MADirectorTimothy N. Yuckman · Birmingham, ALExecTal S. Kerret · New York, NYExecKenneth Bate · Cambridge, MADirectorWilliam Clark · ALEXANDRIA, VAExecGirish Aakalu · Cambridge, MAExecGisela Schwab · CAMBRIDGE, MADirectorDiantha Duvall · CAMBRIDGE, MAExecShawn L. Katz · New York, NYDirectorMelvin L. Kupperman · New York, NYDirectorHoward Mayer · Cambridge, MADirectorRonald Cooper · Cambridge, MADirectorDiantha Duvall · CAMBRIDGE, MAExecGirish Aakalu · Cambridge, MAExecRonald Cooper · Cambridge, MADirectorAli Behbahani · Timonium, MDDirectorMichael Higgins · London, United KingdomDirectorKatrine Bosley · Cambridge, MADirectorGisela Schwab · CAMBRIDGE, MADirectorThomas Davis · Hamilton HM CX, BermudaExecHoward Mayer · Cambridge, MADirectorThomas Davis · Hamilton HM 12, BermudaExecJessica Flechtner · Cambridge, MAExecTom Bacon · HOUSTON, TXDirectorAli Behbahani · South San Francisco, CADirectorMichael Higgins · HOUSTON, TXDirectorAli Behbahani · Seattle, WADirectorKenneth Bate · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗